Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases

Publisher： Karger

E-ISSN： 1421-9832|232|5|566-571

ISSN： 1018-8665

Source： Dermatology, Vol.232, Iss.5, 2016-09, pp. : 566-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Open-Label Nonrandomized Left-Right Comparison of Imiquimod 5% Ointment and Timolol Maleate 0.5% Eye Drops in the Treatment of Proliferating Superficial Infantile Hemangioma

By  

Dermatology, Vol. 230, Iss. 2, 2015-01 ,pp. : 150-155

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Propranolol for the Treatment of Infantile Hemangioma: A Presentation of Ninety-Nine Cases

By  

Dermatology, Vol. 228, Iss. 2, 2014-02 ,pp. : 136-144

Karger

Access to resources Recommend Favorite

Management of Bullous Pemphigoid with Topical Steroids in the Clinical Practice of a Single Center: Outcome at 6 and 12 Months

By  

Dermatology, Vol. 222, Iss. 2, 2011-03 ,pp. : 176-179

Karger

Access to resources Recommend Favorite

Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma

By  

Dermatology, Vol. 219, Iss. 1, 2009-03 ,pp. : 7-21

Karger

Access to resources Recommend Favorite

Adrenal Insufficiency as a Result of Long-Term Misuse of Topical Corticosteroids

By  

Dermatology, Vol. 228, Iss. 4, 2014-04 ,pp. : 289-293

Karger

Access to resources Recommend Favorite